
STEM CELL TREATMENT:
ALL INDIA INSTITUTE OF MEDICAL SCIENCES, New Delhi has marked a global first in pioneering stem cell medicine by injection method. As part of a path-breaking study, conducted from February 2003 to January 2005, 35 cardiac patients were given stem cell treatment and monitored at six, 12 and 18-month intervals. All the patients were brought in at a stage when their hearts were beyond bypass surgery. After six months, 56% of the affected (read dead Muscle) area injected with these cells had shown improvement. After 18 months, this went up to 64%. There will now be a national stem cell center at All India Institute of Medical Sciences, which will coordinate the research and its applications. This opens up a window of hope for the long queue of patients awaiting a heart transplant.
ANTI - TUBERCULOSIS MOLECULE:
In a joint project of the Council of Scientific and industrial Research (CSIR), India and Lupin Laboratories, Mumbai, researchers have discovered a new anti-tubercular molecule for the treatment of tuberculosis. The molecule, LL 4858-SUBOTERN, has the potential to not only treat tuberculosis effectively but also reduce the treatment time significantly. Patents have been filed in India and the US. Researchers said the new molecule was particularly effective against latent tuberculosis, where the disease lingers without showing symptoms.
Please mail your query: QUERY
You are welcome to visit Life Smile India at: www.lifesmileindia.com
You are welcome to write to Life Smile team at: care@lifesmileindia.com
